Bill > A5325

This bill requires various types of health insurance providers in New Jersey, including hospital service corporations, medical service corporations, health service corporations, individual and group health insurance policies, health benefits plans, health maintenance organizations, and state employee health plans, to provide comprehensive coverage for the diagnosis and treatment of two specific pediatric neurological disorders: PANDAS (Pediatric Autoimmune Neuropsychiatric Disorders Associated with Streptococcal Infections) and PANS (Pediatric Acute-onset Neuropsychiatric Syndrome). The coverage must be prescribed or ordered by the treating physician and include a wide range of treatments such as antibiotics, behavioral therapies, medication to manage neuropsychiatric symptoms, immunomodulating medicines, plasma exchange, and intravenous immunoglobulin therapy. The bill mandates that these benefits be provided to the same extent as any other medical condition under the contract, and it will take effect six months after enactment, applying to all insurance contracts delivered, issued, executed, or renewed after that date. This legislation aims to ensure that children suffering from these complex neurological conditions receive comprehensive medical care and support across different types of health insurance plans in New Jersey.

Business and Industry

https://www.njleg.state.nj.us/bill-search/2024/A5325